Navigation Links
3-D MRI technique helps radiologists detect high-risk carotid disease
Date:9/15/2008

OAK BROOK, Ill. Canadian researchers have used three-dimensional magnetic resonance imaging (3-D MRI) to accurately detect bleeding within the walls of diseased carotid arteries, a condition that may lead to a stroke. The results of the study published in the October issue of Radiology suggest the technique may prove to be a useful screening tool for patients at high risk for stroke.

When major arteries are affected by atherosclerosis, fatty deposits, or plaques, accumulate on the inner lining of the vessel walls. Progression of the disease over time leads to narrowing, restricting blood flow or becoming completely blocked.

Until recently, scientists believed that this narrowing, called stenosis, was responsible for most heart attacks or strokes. But new studies have identified the composition of complicated plaques as being a major cause of vascular events and deaths. These complicated plaques are characterized by surface ulcerations, blood clots and bleeding into the vessel wall.

"There's been a major sea change in our research," said Alan R. Moody, F.R.C.R., F.R.C.P., of the University of Toronto. "We now know that the composition of carotid artery plaque is likely to be more predictive of future stroke events than the amount of stenosis in the vessel."

In the study, conducted at the Sunnybrook Health Sciences Centre in Toronto, researchers performed 3-D MRI on the carotid arteries of 11 patients, age 69 to 81. Complicated plaques were then surgically removed from the patients' diseased arteries and analyzed under a microscope.

The research team found strong agreement between the lesions identified by MRI as complicated plaques and the microscopic analysis of the tissue samples.

"With high spatial resolution 3-D MRI, we are able to noninvasively analyze the tissue within the artery wall and identify small bleeds within rupture-prone plaques that may put patients at risk for future stroke," Dr.
'/>"/>

Contact: Linda Brooks
lbrooks@rsna.org
630-590-7762
Radiological Society of North America
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Surgical technique halts cell loss, Parkinsons researchers find
2. New Technique Removes Gallbladder Without External Incisions
3. Vertos Medical Inc. Presents Clinical Data of its MILD™ Procedure at the 5th Annual Innovative Techniques in Spine Surgery Conference in Los Cabos, Mexico
4. Weizmann Institute scientists new technique gets to the root of cancer
5. Corneal transplant technique shows promise in children
6. Researchers hone technique to KO pediatric brain tumors
7. New Technique Harvests Stem Cells at Earlier Stage
8. New ovarian stimulation technique offers more cancer patients the chance to preserve their fertility
9. Automated MRI technique assists in earlier Alzheimers diagnosis
10. Philips Web Site Offers Seniors and Caregivers Tips and Techniques for Preventing Falls
11. SILS Surgical Technique Now Available at MUMC

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)... Networking is everybody,s buzz w... Money. StaffingClub.com enables Recruiters and St...s to connect, share, communicate and close positio...o post their profiles and network with recruiters....09 -- Current Job Market forces everyone to networ...
(Date:11/9/2009)...on of plans finds differences in mood despite simi...thDay News) -- Both a high-fat, low-carbohydrate d...at, high-carb diet appear to help people lose poun...d? Only the low-fat diets will result in long-term...Nov. 9 issue of Archives of Internal Medicine . ,...
(Date:11/9/2009)...ENZHEN, China, Nov. 9 /PRNewswire-FirstCall/ - Har... , announced today that Novartis, a US$41 billion ...85% stake in HTDS, H1N1 Vaccine partner, Zhejiang ...million. Novartis of Switzerland will begin a five...the company will dramatically increase its investm...
(Date:11/9/2009)... Course, to be Offered in April 2...lkit , Cambridge, MA (Voc...sicians for Human Rights (PHR) first inspected a s...an , he realized he would need a team of experts t...ng the site properly was a key first step in secur...
(Date:11/9/2009)...NTA MONICA, Calif., Nov. 9 Actress...n joined philosophy on Saturday to raise awa...t services throughout California by building heali... Enough kits were created to give one to each of ...one of Los Angeles County,s domestic violence shel...
Breaking Medicine News(10 mins):Health News:Launching StaffingClub.com, a New Online Networking Platform for Recruiting and Staffing Professionals 2Health News:To Feel Better, Low-Fat Diet May Be Best 2Health News:To Feel Better, Low-Fat Diet May Be Best 3Health News:Novartis to Acquire Majority Stake in Hard to Treat Diseases' (HTDS.PK) China Subsidiary H1N1 Vaccine Partner for US$125 Million 2Health News:Novartis to Acquire Majority Stake in Hard to Treat Diseases' (HTDS.PK) China Subsidiary H1N1 Vaccine Partner for US$125 Million 3Health News:Novartis to Acquire Majority Stake in Hard to Treat Diseases' (HTDS.PK) China Subsidiary H1N1 Vaccine Partner for US$125 Million 4Health News:Physicians for Human Rights Offers Training in Crime Scene Documentation 2Health News:Physicians for Human Rights Offers Training in Crime Scene Documentation 3Health News:Physicians for Human Rights Offers Training in Crime Scene Documentation 4Health News:Actress Mariska Hargitay and the Joyful Heart Foundation Join philosophy to Serve Women in Crisis Throughout Los Angeles County 2Health News:Actress Mariska Hargitay and the Joyful Heart Foundation Join philosophy to Serve Women in Crisis Throughout Los Angeles County 3
...certain cleaning products reduces lung function, i...IDAY, July 25 (HealthDay News) -- A clean, fresh-s...depending on what type of cleaning and air freshen... (VOC) called 1,4 dicholorobenzene (1,4 DCB), can ...
...BROOK, Ill. July 25, 2008 The American Society ...uidelines on the role of endoscopy in the bariatri...y in the United States and the success in surgical...elines discuss endoscopy in the preoperative patie...
... July 25 BeaconEquity.com announces the,availabil... Investors can view all of the daily trading notes..., Today,s Trade Alerts include: DUSA Pharmaceutic...c. (Nasdaq: AFFX ) and,Abaxis Inc. (Nasdaq: ABAX...
...nCotter Releases Results of Fourth Annual Physicia...ey, DETROIT, July 25 Sullivan, Cotter and Associ...of physician on-call pay rates and,practices, the ...ctices and rates paid for 33 physician specialty a...
...ays of Marketing Exclusivity Begins -, CORONA, Ca... WPI ), a leading specialty pharmaceutical,compan...ed commercial,shipment of its Omeprazole Delayed-R...f marketing exclusivity for being the,first to fil...
...McKesson Corporation Executive, Robert J. Reilly, ...c.,( http://www.aethon.com ), the leading develope...istics, today announced that Robert J. Reilly has,... Corporation,s Specialty Pharmacy Division, brings...
Other Medicine News:Health News:Health Hazards in Household Cleaners Exposed 2Health News:Health Hazards in Household Cleaners Exposed 3Health News:ASGE issues guidelines on the role of endoscopy in the bariatric surgery patient 2Health News:ASGE issues guidelines on the role of endoscopy in the bariatric surgery patient 3Health News:BeaconEquity.com Issues Technical Trade Alerts on Healthcare/Pharmaceutical Stocks: DUSA, MBRK, NOVA, ADLR, AFFX, ABAX 2Health News:BeaconEquity.com Issues Technical Trade Alerts on Healthcare/Pharmaceutical Stocks: DUSA, MBRK, NOVA, ADLR, AFFX, ABAX 3Health News:Hospital Expenditures for Physician On-Call Pay Rates Nearly Double 2Health News:Hospital Expenditures for Physician On-Call Pay Rates Nearly Double 3Health News:Watson Launches Omeprazole Delayed-Release Capsules, 40MG 2Health News:Aethon, Inc. Names New Chief Financial Officer 2
(Date:11/9/2009)...PLEASANTON, Calif., Nov. 9 /PRNewswire-FirstCall/ ...leader in device-based mechanical circulatory supp... hearts, said today that it will be participating ...rence on Tuesday, November 10. ,, The presentat...ive officer, will begin at 8 a.m., Pacific Standar...
(Date:11/9/2009)...SAN DIEGO, Nov. 9 Volcan...velopment, manufacture and sales of products for t...ral artery disease, said today that it will be par...cular Conference on Tuesday, November 10. ,, Th...chief executive officer, will begin at 1 p.m., Pac...
(Date:11/9/2009)...BIRMINGHAM, Ala., Nov. 9 ...that it will host an investor conference call at 1...9, to discuss its 2009 third quarter operating res...tely an hour following the conclusion of the confe.../cgi-bin/prnh/20080812/CLTU111LOGO ) ,, Plea...
Breaking Medicine Technology:Volcano Corporation Presentation at Canaccord Adams Conference to Be Webcast 2Emission capture study funded for paper industry 10353 1Emission capture study funded for paper industry 10353 2Emission capture study funded for paper industry 10353 3Chimpanzees help each other on request but not voluntarily 10350 1Chimpanzees help each other on request but not voluntarily 10350 2SIMNSA is added to the Satori Global Network 26amp 3B 238482 3B in Mexico to Offer U S Employers Cross Border Health Benefit Options 59446 1SIMNSA is added to the Satori Global Network 26amp 3B 238482 3B in Mexico to Offer U S Employers Cross Border Health Benefit Options 59446 2
...LIS, France, Nov. 20 NicOx S.A. (Eurolist:,COX) t...as dosed the first,patients in a phase 2 proof of ...Pulmonary Disease (COPD) - see TOPIGEN press relea... the first assessment of TPI 1020,s,potential acti...d novel,anti- inflammatory licensed by TOPIGEN fro...
...strated powerful mean blood pressure reductions of... mm Hg diastolic blood pressure (DBP),at five week...ne in a study of patients with se...BP reductions of 27.1/14.6 mm Hg (SBP/DBP), at 8 .../DBP) reductions, respectively for irbesartan and...
Other Medicine Technology:NicOx Announces TOPIGEN Initiates Phase 2 Proof of Concept Study in COPD for TPI 1020 2NicOx Announces TOPIGEN Initiates Phase 2 Proof of Concept Study in COPD for TPI 1020 3NicOx Announces TOPIGEN Initiates Phase 2 Proof of Concept Study in COPD for TPI 1020 4NicOx Announces TOPIGEN Initiates Phase 2 Proof of Concept Study in COPD for TPI 1020 5NicOx Announces TOPIGEN Initiates Phase 2 Proof of Concept Study in COPD for TPI 1020 6NicOx Announces TOPIGEN Initiates Phase 2 Proof of Concept Study in COPD for TPI 1020 7Powerful New Efficacy Data in Moderate and Severe Hypertensive Patients Supports FDA Approval of AVALIDE(R) (Irbesartan-Hydrochlorothiazide) as the First Combination Therapy for Initial Use in Patients Likely to Need Multiple Drugs to Achieve Their Blood 2Powerful New Efficacy Data in Moderate and Severe Hypertensive Patients Supports FDA Approval of AVALIDE(R) (Irbesartan-Hydrochlorothiazide) as the First Combination Therapy for Initial Use in Patients Likely to Need Multiple Drugs to Achieve Their Blood 3Powerful New Efficacy Data in Moderate and Severe Hypertensive Patients Supports FDA Approval of AVALIDE(R) (Irbesartan-Hydrochlorothiazide) as the First Combination Therapy for Initial Use in Patients Likely to Need Multiple Drugs to Achieve Their Blood 4Powerful New Efficacy Data in Moderate and Severe Hypertensive Patients Supports FDA Approval of AVALIDE(R) (Irbesartan-Hydrochlorothiazide) as the First Combination Therapy for Initial Use in Patients Likely to Need Multiple Drugs to Achieve Their Blood 5Powerful New Efficacy Data in Moderate and Severe Hypertensive Patients Supports FDA Approval of AVALIDE(R) (Irbesartan-Hydrochlorothiazide) as the First Combination Therapy for Initial Use in Patients Likely to Need Multiple Drugs to Achieve Their Blood 6Powerful New Efficacy Data in Moderate and Severe Hypertensive Patients Supports FDA Approval of AVALIDE(R) (Irbesartan-Hydrochlorothiazide) as the First Combination Therapy for Initial Use in Patients Likely to Need Multiple Drugs to Achieve Their Blood 7
COULTER AcT diff2 (Recertified)
mini VIDAS - Recertified
ACE Alera
...oratory and a worldwide leader in innovative labor...ensive test menu of highly complex and unique medi...d by the University of Utah, ARUP Laboratories' cl...rsity teaching hospitals and children's hospitals,...
Medicine Products: